Head and neck cancers are a group of cancers arising from the mucosal lining of the upper aerodigestive tract — the surfaces of the mouth (oral cavity), nose (nasal cavity), sinuses, throat (pharynx: nasopharynx, oropharynx, hypopharynx), and voice box (larynx). The vast majority are squamous cell carcinomas. Salivary gland tumours and nasopharyngeal carcinoma have distinct biology and risk factors. Head and neck cancers are collectively the 6th most common cancer globally. In Ethiopia and East Africa, oral cavity and laryngeal cancers predominate, strongly associated with tobacco and khat (qat) chewing habits.
Head & Neck Cancer
Oral, throat, and laryngeal cancers — tobacco and alcohol are the main risk factors
📖 What Are Head & Neck Cancers?
🔍 Warning Signs & Symptoms
Do not ignore these symptoms — they require prompt medical evaluation:
- A sore or ulcer in the mouth that does not heal within 3 weeks
- A painless lump or swelling in the neck (enlarged lymph node)
- Persistent hoarseness or voice change lasting more than 3 weeks
- Difficulty swallowing (dysphagia) or pain on swallowing
- Persistent sore throat not associated with cold or flu
- White or red patches inside the mouth (leukoplakia or erythroplakia — pre-cancerous changes)
- Persistent earache on one side (can be referred pain from the throat)
- Numbness of the lip or chin
- Unexplained weight loss and difficulty eating
🩺 Diagnosis
Clinical examination: careful inspection of the mouth, throat, and neck; laryngoscopy (looking at the voice box). Nasopharyngoscopy or flexible fibreoptic laryngoscopy: visualises the nasopharynx, oropharynx, and larynx. Biopsy of the primary tumour: the definitive diagnostic test — tissue is sent for histopathology and HPV/p16 immunohistochemistry for oropharyngeal tumours. CT and/or MRI of the head, neck, and chest: essential for staging, showing invasion of adjacent structures and lymph node involvement. PET-CT: detects nodal disease and distant metastases. HPV status (p16 IHC) guides prognosis for oropharyngeal cancer — HPV-positive tumours have better outcomes.
📊 Staging
Head and neck cancers are staged using the TNM system (tumour size, node involvement, metastases). Stage I–II: Small tumour confined to the primary site; no lymph node involvement — high cure rates with single modality treatment. Stage III: Larger tumour and/or involvement of regional lymph nodes — combined modality treatment needed. Stage IVA: Moderately advanced local or regional disease — still potentially curable with aggressive multimodal treatment. Stage IVB: Very advanced local disease (invading carotid artery, skull base). Stage IVC: Distant metastases — palliative intent. Nasopharyngeal cancer staging follows a separate classification.
💊 Treatment Options
Treatment depends on the site, stage, and HPV status. NCCN Guidelines recommend:
- Surgery — For accessible oral cavity cancers; resection of the primary tumour and neck dissection for lymph nodes
- Radiation therapy — Definitive treatment for laryngeal and pharyngeal cancers (preserves voice and swallowing)
- Concurrent chemoradiation — Cisplatin + radiation; standard for Stage III–IV head and neck squamous cell carcinoma
- Induction chemotherapy — TPF (docetaxel, cisplatin, 5-FU) to shrink large tumours before definitive treatment
- Cetuximab — Targeted therapy option for patients unable to tolerate platinum chemotherapy
- Immunotherapy — Pembrolizumab or nivolumab for recurrent/metastatic head and neck squamous cell carcinoma
- Speech and swallowing rehabilitation — Essential after surgery or radiation to the throat/larynx
🛡️ Prevention & Early Detection
Tobacco cessation is the single most impactful preventive measure — stopping at any age reduces risk. Avoid all forms of tobacco: cigarettes, hookah (shisha), smokeless tobacco, and khat chewing. Limit alcohol consumption — alcohol acts synergistically with tobacco to greatly increase risk. HPV vaccination in adolescents also prevents HPV-associated oropharyngeal cancer. Regular dental check-ups allow early identification of suspicious oral lesions. White or red patches in the mouth (leukoplakia or erythroplakia) are pre-cancerous; biopsy these lesions to exclude early cancer. Community health workers in Ethiopia should be trained to recognise oral lesions during routine visits.
This article is for educational purposes only. It is based on current NCCN Guidelines for Patients® and WHO recommendations, contextualised for Ethiopia and East Africa. It does not replace advice, diagnosis, or treatment from a qualified healthcare provider. Ethiopian patients should consult the Tikur Anbessa Specialized Hospital Oncology Department, Addis Ababa, for clinical care.